NewLimit

Developer of precision medicines designed for epigenetic reprogramming to restore youthful function in aging cells. The company applies single-cell genomics, machine learning, and functional assays to...

Healthcare

South San Francisco, CA, United States

Founded 2021

43 employees

Website

Valuation

$1.6B

Market implied

Share Price

N/A

Total Raised

$247.3M

Last Round

N/A

Investors

+23 other investors

View all 23 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock NewLimit's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required